RSS-Feed abonnieren
DOI: 10.1055/s-0028-1112132
© Georg Thieme Verlag KG Stuttgart · New York
COMT Val158Met Polymorphism is Associated with Cognitive Flexibility in a Signal Discrimination Task in Schizophrenia
Publikationsverlauf
received 13.08.2008
revised 11.11.2008
accepted 13.11.2008
Publikationsdatum:
07. Juli 2009 (online)

Abstract
Background: Associations between the well-known functional single nucleotide polymorphism Val158Met in the gene encoding catechol-O-methyltransferase (COMT) and cognitive do-mains affected in schizophrenia are inconsistent regarding directionality and specific impact and call for a more fundamental cognitive endophenotype. Recent studies suggest that the COMT genotype contributes to cognitive flexibility, a fundamental cognitive ability that potentially influences an individual's performance in a variety of other neurocognitive tasks.
Methods: We investigated the association between COMT Val158Met genotype and cognitive flexibility as assessed by signal discrimination in the Continuous Performance Test – Identical Pairs version in a cohort of 111 German schizophrenic patients.
Results: COMT genotype was significantly associated with signal discrimination index d’ in schizophrenia. The Val/Val genotype was associated with the highest and the Met/Met genotype with the lowest scores; heterozygous individuals displayed an intermediate performance.
Conclusions: Our data suggest that allelic variation at the COMT Val158Met locus may influence signal discrimination capacity in schizophrenia and confirm that Val loading, probably due to decreased prefrontal dopamine availability, is associated with greater cognitive flexibility, which in turn may influence other cognitive measures that have been associated with COMT to date.
References
- 1 Barnett JH, Jones PB, Robbins TW. et al . Effects of the catechol-O-methyltransferase val(158)met polymorphism on executive function: a meta-analysis of the Wisconsin Card Sort Test in schizophrenia and healthy controls. Mol Psychiatry. 2007; 12 502-509
- 2 Bilder RM, Volavka J, Lachmann HM. et al . The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology. 2004; 29 1943-1961
- 3 Cornblatt BA, Risch NJ, Faris G. et al . The Continuous Performance Test, Identical Pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatry Res. 1988; 26 223-238
- 4 DeRosse P, Funke B, Burdick KE. et al . COMT genotype and manic symptoms in schizophrenia. Schizophr Res. 2006; 87 28-31
- 5 Egan MF, Goldberg TE, Kolachana BS. et al . Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 2001; 98 6917-6922
- 6 Gallinat J, Bajbouj M, Sander T. et al . Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry. 2003; 54 40-48
- 7 Goldberg TE, Egan MF, Gescheidle T. et al . Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia. Arch Gen Psychiatry. 2003; 60 889-896
- 8 Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13 261-276
- 9 Lehrl S, Triebig G, Fischer B. Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand. 1995; 91 335-345
- 10 Malhotra AK, Kestler LJ, Mazzanti C. et al . A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002; 159 652-654
- 11 Mobascher A, Winterer G. The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Pharmacopsychiatry. 2008; 41 ((Suppl. 1)) S51-S59
- 12 Nolan KA, Bilder RM, Lachmann HM. et al . Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry. 2004; 161 359-361
- 13 Opgen-Rhein C, Neuhaus AH, Urbanek C. et al . Executive attention in the Attention Network Test: reduced conflict effect in schizophrenic males and the impact of COMT Val108/158Met genotype. Schizophr Res. 2008; 103 169-177
- 14 Puls I, Gallinat J. The concept of endophenotypes in psychiatric diseases meeting the expectations?. Pharmacopsychiatry. 2008; 41 ((Suppl. 1)) S37-S43
- 15 Rolls ET, Loh M, Deco G. et al . Computational models of schizophrenia and dopamine modulation in the prefrontal cortex. Nat Rev Neurosci. 2008; 9 696-709
- 16 Stefanis NC, van Os J, Avramopoulos D. et al . Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: tuning rather than improving performance. Am J Psychiatry. 2005; 162 1752-1754
- 17 Tunbridge EM, Harrison PJ, Weinberger DR. Catechol-O-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006; 60 141-151
- 18 Vijayraghavan S, Wang M, Birnbaum SG. et al . Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nature Neurosci. 2007; 10 376-384
-
19 Wechsler D.
Wechsler Adult Intelligence Scale, third edition . San Antonio, TX: The Psychological Corporation 1997 - 20 Winterer G, Egan MF, Kolachana BS. et al . Prefrontal electrophysiologic “noise” and catechol-O-methyltransferase genotype in schizophrenia. Biol Psychiatry. 2006; 60 578-584
Correspondence
A. H. NeuhausMD
Department of Psychiatry and Psychotherapy
Charité University Medicine Berlin
Campus Benjamin Franklin
Eschenallee 3
14050 Berlin
Germany
Telefon: +49/30/8445 86 61
Fax: +49/30/8445 83 93
eMail: andres.neuhaus@charite.de